Electronic Patient-Reported Outcome Monitoring System Beneficial
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 14, 2025 -- Implementation of an electronic patient-recorded outcome (ePRO) monitoring system improves patient-physician communication in cardiovascular care, according to a study published online Jan. 14 in JAMA Network Open.
Shuhei Yamashita, M.D., from the Keio University School of Medicine in Tokyo, and colleagues conducted an open-label, multicenter, randomized phase 2 trial conducted from October 2022 to October 2023, which focused on the implementation and evaluation of an ePRO monitoring system in outpatient clinics. This monitoring system was developed during phase 1 of the multiphase trial, using feedback from patients and physicians. Fifty participants with a clinical diagnosis of heart failure, atrial fibrillation, or coronary artery disease were randomly assigned to the ePRO or control group in a 1:1 ratio; those in the ePRO group completed the 12-item Kansas City Cardiomyopathy Questionnaire, Atrial Fibrillation Effect on Quality-of-Life Questionnaire, or Seattle Angina Questionnaire before clinical examination. Outcome measures included patient satisfaction, quality of information (QOI) provided by physicians, and disease knowledge assessed using questionnaires including the Patient Satisfaction Questionnaire (PSQ).
The researchers found that the ePRO group had significant improvements in mean PSQ score and QOI score regarding treatment compared with the control group. A greater increase in the PSQ score regarding communication was seen in the ePRO group.
"This multicenter pilot randomized clinical trial demonstrated the feasibility and efficacy of the electronic monitoring of PROs in cardiovascular care," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine
MONDAY, June 23, 2025 -- The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately...
Gluten-Stimulated Interleukin-2 Secretion Useful for Diagnosing Celiac Disease
MONDAY, June 23, 2025 -- Gluten-stimulated interleukin-2 (IL-2) secretion is useful for diagnosis of celiac disease (CeD), according to a study published online June 9 in...
Minor Complications Up for Black Patients After Weight-Loss Surgery
MONDAY, June 23, 2025 -- Black patients have a higher incidence of minor complications after metabolic and bariatric surgery, according to a study presented at the annual meeting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.